“…IVL is classified as DLBCL subtype, according to the new WHO classification (17). IVL is characterized by intravascular proliferation of malignant lymphomatous cells, which frequently invade the central nervous system (CNS), skin, lungs and kidneys (12,18,19). Both pituitary and adrenal involvement are frequent in IVL patients (12,20,21).…”